Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway

The Journal of Immunology : Official Journal of the American Association of Immunologists
Minoru TakahashiT Fujita

Abstract

The complement system plays an important role in innate immunity. In the lectin complement pathway, mannose-binding lectin (MBL) and ficolins act as recognition molecules, and MBL-associated serine protease (MASP) is a key enzyme. It has been suggested that MASP-2 is responsible for the activation of C4. Other serine proteases (MASP-1 and MASP-3) are also associated with MBL or ficolins; however, their functions are still controversial. In this study, a MASP-1- and MASP-3-deficient mouse model (MASP1/3(-/-)) was generated by a gene targeting strategy to investigate the roles of MASP-1 and MASP-3 in the lectin pathway. Serum derived from MASP1/3(-/-) mice showed significantly lower activity of both C4 and C3 deposition on mannan-agarose, and this low activity was restored by the addition of recombinant MASP-1. MASP-1/3-deficient serum showed a significant delay for activation of MASP-2 compared with normal serum. Reconstitution of recombinant MASP-1 in MASP-1/3-deficient serum was able to promote the activation of MASP-2. From these results, we propose that MASP-1 contributes to the activation of the lectin pathway, probably through the activation of MASP-2.

References

Aug 14, 1978·Biochemical and Biophysical Research Communications·S Inoue, M Iwasaki
Aug 31, 1982·Biochemical and Biophysical Research Communications·I IharaM Kawakami
Feb 2, 1996·The Journal of Biological Chemistry·M MatsushitaT Mizuochi
Jul 6, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S ThielJ C Jensenius
Aug 5, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·T Vorup-JensenJ C Jensenius
Aug 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M MatsushitaT Fujita
Apr 5, 2001·The New England Journal of Medicine·M J Walport
Apr 12, 2001·The New England Journal of Medicine·M J Walport
Aug 31, 2001·The Journal of Biological Chemistry·V RossiG J Arlaud
May 30, 2002·Nature Reviews. Immunology·Teizo Fujita
Jan 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Géza AmbrusPéter Závodszky
Apr 3, 2004·The Journal of Biological Chemistry·Ce-Belle Chen, Russell Wallis
Nov 8, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Russell WallisWilhelm J Schwaeble

❮ Previous
Next ❯

Citations

Sep 19, 2008·Journal of Cellular and Molecular Medicine·Maciej M MarkiewskiJohn D Lambris
Jul 1, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·József DobóPéter Gál
May 12, 2010·The Journal of Experimental Medicine·Motomu HashimotoShimon Sakaguchi
Apr 20, 2011·Proceedings of the National Academy of Sciences of the United States of America·Wilhelm J SchwaebleCordula M Stover
Dec 14, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Laura R La BonteGregory L Stahl
Nov 15, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yuichi EndoTeizo Fujita
Apr 9, 2013·Archivum Immunologiae Et Therapiae Experimentalis·Misao MatsushitaTeizo Fujita
Jul 30, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nirmal K BandaV Michael Holers
Sep 24, 2019·Frontiers in Neuroscience·Teresa TsaiStephanie C Joachim
Apr 11, 2020·Endocrinology·Penny A F WhileyKate L Loveland
Nov 22, 2008·Biochemical Society Transactions·Peter Garred
Aug 12, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Márton MegyeriPéter Gál
Apr 10, 2010·Critical Reviews in Microbiology·Markus MezgerJuergen Loeffler
Aug 26, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Daisuke IwakiTeizo Fujita
Sep 10, 2014·Proceedings of the National Academy of Sciences of the United States of America·Søren E DegnSteffen Thiel
Jun 21, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Søren E DegnSteffen Thiel
Jan 23, 2016·Immunogenetics·Helga BjarnadottirBjorn Runar Ludviksson
Jan 21, 2016·Annual Review of Biomedical Engineering·Balaji NarasimhanJulia E Vela Ramirez
Sep 2, 2016·Proceedings. Biological Sciences·Steven D QuistadForest L Rohwer
Jun 13, 2018·Frontiers in Immunology·V Michael Holers, Nirmal K Banda
Mar 29, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Mika TakasumiHideharu Sekine
Aug 1, 2020·Frontiers in Immunology·Jack MellorsMiles Carroll
Dec 17, 2009·Cell Research·Jason R Dunkelberger, Wen-Chao Song
Sep 12, 2013·PloS One·Christian Gytz AmmitzbøllJens Christian Jensenius
Sep 28, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nirmal K BandaV Michael Holers
Jul 27, 2012·Journal of Clinical Immunology·Sébastien DamiensBoualem Sendid
Dec 11, 2019·The Journal of Immunology : Official Journal of the American Association of Immunologists·Takeshi MachidaHideharu Sekine
Aug 6, 2020·International Journal of Molecular Sciences·Gabriela GajekMaciej Cedzyński
Feb 5, 2013·The Journal of Biological Chemistry·Christel R BrinkmannSøren E Degn
Dec 30, 2009·The Journal of Experimental Medicine·Minoru TakahashiTeizo Fujita
Sep 12, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Søren E DegnSteffen Thiel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.